Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Keppra in Japanese Pediatric Patients With Partial Seizures
NCT01063764Phase 3Completed
- Sponsor
- UCB
- Start
- Jan 2010
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of levetiracetam in epilepsy, sponsored by UCB. Primary endpoints: Change From Baseline in Partial Seizure Frequency Per Week Over the 14-weeks Treatment Period at 22 weeks and Incidence of Treatment-Emergent Adverse Events During the Second Period at 3 years. Started Jan 2010; status: completed.
02
Drugs
levetiracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT01063764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01063764.